Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Enterprise Value (2022 - 2025)

Envoy Medical's Enterprise Value history spans 4 years, with the latest figure at -$3.7 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$3.7 million for Q4 2025, up 31.81% from a year ago — trailing twelve months through Dec 2025 was -$3.7 million (up 31.81% YoY), and the annual figure for FY2025 was -$3.7 million, up 31.81%.
  • Enterprise Value for Q4 2025 was -$3.7 million at Envoy Medical, down from -$3.6 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$68000.0 in Q2 2023 to a low of -$22.2 million in Q3 2023.
  • The 4-year median for Enterprise Value is -$3.7 million (2025), against an average of -$4.2 million.
  • Peak annual rise in Enterprise Value hit 85.74% in 2023, while the deepest fall reached 7264.31% in 2023.
  • Year by year, Enterprise Value stood at -$183000.0 in 2022, then crashed by 2205.46% to -$4.2 million in 2023, then decreased by 29.96% to -$5.5 million in 2024, then skyrocketed by 31.81% to -$3.7 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$3.7 million, -$3.6 million, and -$5.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.